Approvals/CIMA-AEMPS/STRIBILD 150MG/150MG/200MG/245MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Approved

STANDARD

STRIBILD 150MG/150MG/200MG/245MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Gilead Sciences Ireland Unlimited Company🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: eeca0b99186e0897
Drug Cima Aemps Name: STRIBILD 150MG/150MG/200MG/245MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: 113830001IP
Holder Company Name: Gilead Sciences Ireland Unlimited Company
Marketing Company Name: Abacus Medicine A/S
Holder Company Detail Path: /organization/gilead-sciences-ireland-unlimited-company
Authorization Date: 2024-04-22
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 150 MG/150 MG/200MG/ 245 MG
Route Of Administration: VÍA ORAL
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Gilead Sciences Ireland Unlimited Company
Company Detail Path: /organization/gilead-sciences-ireland-unlimited-company

COBICISTAT

150 mg

EMTRICITABINA

200 mg

TENOFOVIR DISOPROXILO FUMARATO

245 mg

ELVITEGRAVIR

150 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 22, 2024

Approval ID

eeca0b99186e0897

Type

Standard